The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tissue assessment of therapeutic responses to neoadjuvant short course radiotherapy with and without anti-CD40 immunotherapy sotigalimab (sotiga) in rectal cancer.
 
Todd Anthony Aguilera
Stock and Other Ownership Interests - AKSO Biopharmaceutical; Avelas Biosciences
Research Funding - Apexigen (Inst); Galera Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Stanford licensed to AKSO; UCSD licensed to Avelas
 
Eslam Elghonaimy
No Relationships to Disclose
 
Nina Niu Sanford
No Relationships to Disclose
 
Syed Mohammad Ali Kazmi
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
 
Javier Salgado Pogacnik
No Relationships to Disclose
 
Adel Kardosh
Consulting or Advisory Role - Astellas Pharma; Astex Pharmaceuticals; Eisai; Exelixis; Exelixis; Genentech
Research Funding - Natera
 
Brendan Paulman
No Relationships to Disclose
 
Cassandra Mufich
No Relationships to Disclose
 
Shaun Goodyear
Consulting or Advisory Role - PDX Pharmacy
 
Emina Huang
No Relationships to Disclose
 
Amy Little Jones
No Relationships to Disclose
 
Georgios Karagkounis
No Relationships to Disclose
 
Radhika Kainthla
No Relationships to Disclose
 
Fadwa Ali
No Relationships to Disclose
 
Salwan Al Mutar
No Relationships to Disclose
 
Aravind Sanjeevaiah
No Relationships to Disclose
 
Xiaodong Yang
Employment - Apexigen
Leadership - Apexigen
Stock and Other Ownership Interests - Apexigen
Consulting or Advisory Role - CS Bay Therapeutics
 
Robert D. Timmerman
Research Funding - Accuray (Inst); Elekta (Inst); Varian Medical Systems (Inst)